홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2-(3-bromophenyl)-N-methylacetamide → HCID 18668613, 화합물

HRID 1059216
인쇄

반응식

HRID 1059216 반응식
[OH:1][C:2]([C:30]1[CH:35]=[CH:34][C:33](B(O)O)=[CH:32][CH:31]=1)([C:6]1[N:7]=[CH:8][N:9]([C:11]([C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)[C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)[CH:10]=1)[CH:3]([CH3:5])[CH3:4].Br[C:40]1[CH:41]=[C:42]([CH2:46][C:47]([NH:49][CH3:50])=[O:48])[CH:43]=[CH:44][CH:45]=1>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[OH:1][C:2]([C:30]1[CH:35]=[CH:34][C:33]([C:44]2[CH:45]=[CH:40][CH:41]=[C:42]([CH2:46][C:47]([NH:49][CH3:50])=[O:48])[CH:43]=2)=[CH:32][CH:31]=1)([C:6]1[N:7]=[CH:8][N:9]([C:11]([C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)[C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)[CH:10]=1)[CH:3]([CH3:5])[CH3:4]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 186685292-(3-bromophenyl)-N-methylacetamideHCID 186685784-[1-hydroxy-2-methyl-1-(1-trityl-1H-imidazol-4-yl)propyl]phenylboronic acid

생성물 1

HCID 18668613HCID 18668613, 화합물수율 23.5%

시약·촉매·용매 1

HCID 178418397HCID 178418397, 화합물촉매

실험 절차

By the reaction in the same manner as in Example 33-(ii) using 4-[1-hydroxy-2-methyl-1-(1-trityl-1H-imidazol-4-yl)propyl]phenylboronic acid (3.47 g), 2-(3-bromophenyl)-N-methylacetamide (0.93 g) and tetrakis(triphenylphosphine)palladium(0) (0.21 g), the title compound (580 mg) was obtained as colorless powder crystals.

출처 및 근거

ORD 기록
ord-9700cb29194447428dbd7dc8793de71f
출처 데이터셋
uspto-grants-2003_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06518257B1

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트